• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

难治性身体部位银屑病的流行病学:来自丹麦皮肤队列的数据。

Epidemiology of psoriasis in hard-to-treat body locations: data from the Danish skin cohort.

作者信息

Egeberg Alexander, See Kyoungah, Garrelts Alyssa, Burge Russel

机构信息

Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Kildegårdsvej 28, 2900, Hellerup, Denmark.

Eli Lilly and Company, Indianapolis, Indiana, USA.

出版信息

BMC Dermatol. 2020 May 20;20(1):3. doi: 10.1186/s12895-020-00099-7.

DOI:10.1186/s12895-020-00099-7
PMID:32434510
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7238562/
Abstract

BACKGROUND

Having psoriasis in hard-to-treat areas, i.e. the scalp, face, palms, soles, nails, and genitals, respectively, can impair patients' quality of life. We investigated the prevalence of hard-to-treat body locations of psoriasis, and described patients' clinical and demographic characteristics, and quality of life impacts in a population-based cohort.

METHODS

We performed a cross-sectional study using a total of 4016 adults (≥18 years) with psoriasis from the Danish Skin Cohort. Groups were compared to patients without involvement of hard-to-treat areas.

RESULTS

The most frequently affected hard-to-treat area was the scalp (43.0%), followed by the face (29.9%), nails (24.5%), soles (15.6%), genitals (14.1%), and palms (13.7%), respectively. Higher prevalence was generally seen with increasing psoriasis severity. Among all patients 64.8, 42.4, and 21.9% of patients had involvement of ≥1, ≥2, or ≥ 3 hard-to-treat areas. Those with involvement of certain hard-to-treat areas such as hands, feet, and genitals had clinically relevant DLQI impairments. Having involvement of one hard-to-treat area was significantly associated with other hard-to-treat areas affected even after adjusting for age, sex, and psoriasis severity.

CONCLUSION

Psoriasis commonly affects hard-to-treat locations, even in patients with mild disease. For some of these areas, patient-reported disease burden, e.g. as measured by DLQI, is impaired.

摘要

背景

银屑病出现在难以治疗的部位,即头皮、面部、手掌、脚底、指甲和生殖器,会损害患者的生活质量。我们调查了银屑病难以治疗的身体部位的患病率,并描述了基于人群队列中患者的临床和人口统计学特征以及对生活质量的影响。

方法

我们使用丹麦皮肤队列中总共4016名成年(≥18岁)银屑病患者进行了一项横断面研究。将这些组与未累及难以治疗部位的患者进行比较。

结果

最常受累的难以治疗的部位是头皮(43.0%),其次是面部(29.9%)、指甲(24.5%)、脚底(15.6%)、生殖器(14.1%)和手掌(13.7%)。随着银屑病严重程度的增加,患病率通常更高。在所有患者中,分别有64.8%、42.4%和21.9%的患者累及≥1个、≥2个或≥3个难以治疗的部位。累及某些难以治疗部位(如手、脚和生殖器)患者的皮肤病生活质量指数(DLQI)有临床相关损害。即使在调整年龄、性别和银屑病严重程度后,累及一个难以治疗的部位也与其他受影响的难以治疗的部位显著相关。

结论

银屑病通常会影响难以治疗的部位,即使是轻度疾病患者。对于其中一些部位,患者报告的疾病负担(例如通过DLQI测量)会受到损害。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21fb/7238562/16ee4c0d214a/12895_2020_99_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21fb/7238562/43a69432d40d/12895_2020_99_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21fb/7238562/16ee4c0d214a/12895_2020_99_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21fb/7238562/43a69432d40d/12895_2020_99_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21fb/7238562/16ee4c0d214a/12895_2020_99_Fig2_HTML.jpg

相似文献

1
Epidemiology of psoriasis in hard-to-treat body locations: data from the Danish skin cohort.难治性身体部位银屑病的流行病学:来自丹麦皮肤队列的数据。
BMC Dermatol. 2020 May 20;20(1):3. doi: 10.1186/s12895-020-00099-7.
2
Association between the severity of hard-to-treat psoriasis and the prevalence of metabolic syndrome: A hospital-based cross-sectional study in Jakarta, Indonesia.印尼雅加达一项基于医院的横断面研究:难治性银屑病严重程度与代谢综合征患病率的相关性。
PLoS One. 2024 Apr 29;19(4):e0302391. doi: 10.1371/journal.pone.0302391. eCollection 2024.
3
Management of difficult to treat locations of psoriasis. Scalp, face, flexures, palm/soles and nails.银屑病难治部位的管理。头皮、面部、褶皱部位、手掌/足底及指甲。
Curr Probl Dermatol. 2009;38:160-171. doi: 10.1159/000232309. Epub 2009 Jul 28.
4
Underdiagnosed and undertreated psoriasis: Nuances of treating psoriasis affecting the scalp, face, intertriginous areas, genitals, hands, feet, and nails.未被诊断和治疗不足的银屑病:治疗影响头皮、面部、皱褶部位、生殖器、手部、足部和指甲的银屑病的细微差别。
Dermatol Ther. 2018 May;31(3):e12589. doi: 10.1111/dth.12589. Epub 2018 Mar 6.
5
Disease burden and treatment needs of patients with psoriasis in sexually-sensitive and visible body areas: results from a large-scale survey in routine care.在性敏感和可见身体部位患有银屑病的患者的疾病负担和治疗需求:来自常规护理的大规模调查结果。
Eur J Dermatol. 2020 Jun 1;30(3):267-278. doi: 10.1684/ejd.2020.3768.
6
Characterization of Patients with Psoriasis in Challenging-to-Treat Body Areas in the Corrona Psoriasis Registry.在 Corrona 银屑病注册研究中,对治疗困难的身体部位银屑病患者的特征进行描述。
Dermatology. 2021;237(1):46-55. doi: 10.1159/000504841. Epub 2020 Jan 21.
7
Topology of psoriasis in routine care: results from high-resolution analysis of 2009 patients.常规护理中的银屑病拓扑结构:2009 例患者的高分辨率分析结果。
Br J Dermatol. 2019 Aug;181(2):358-365. doi: 10.1111/bjd.17403. Epub 2019 Jan 24.
8
Factors associated with patient-reported importance of skin clearance among adults with psoriasis and atopic dermatitis.与成人银屑病和特应性皮炎患者报告的皮肤清除重要性相关的因素。
J Am Acad Dermatol. 2019 Oct;81(4):943-949. doi: 10.1016/j.jaad.2019.06.018. Epub 2019 Jun 13.
9
Sex-related impairment and patient needs/benefits in anogenital psoriasis: Difficult-to-communicate topics and their impact on patient-centred care.性相关障碍与肛门生殖器银屑病患者的需求/获益:难以沟通的话题及其对以患者为中心的护理的影响。
PLoS One. 2020 Jul 1;15(7):e0235091. doi: 10.1371/journal.pone.0235091. eCollection 2020.
10
Characterization of psoriasis patients in special body areas: real-world evidence from the Chinese Psoriasis Standardized Diagnosis and Treatment Center.特殊部位银屑病患者的特征:来自中国银屑病标准化诊断与治疗中心的真实世界证据。
J Dermatolog Treat. 2024 Dec;35(1):2337264. doi: 10.1080/09546634.2024.2337264. Epub 2024 Jul 11.

引用本文的文献

1
Long-Term Impact of Guselkumab on Skin, Sexuality, and Perceived Stigmatization in Patients With Psoriasis in Routine Clinical Practice: Week 76 Effectiveness and Safety Results From the Prospective German Multicenter G-EPOSS Study.古塞库单抗对日常临床实践中银屑病患者皮肤、性功能及感知耻辱感的长期影响:德国前瞻性多中心G-EPOSS研究第76周的有效性和安全性结果
J Dermatol. 2025 Sep;52(9):1368-1381. doi: 10.1111/1346-8138.17866. Epub 2025 Aug 9.
2
Long-Term Safety and Efficacy of Risankizumab to Treat Moderate-to-Severe Plaque Psoriasis: Final LIMMitless Phase 3, Open-Label Extension Trial Results.瑞莎珠单抗治疗中度至重度斑块状银屑病的长期安全性和有效性:LIMMitless 3期最终开放标签扩展试验结果
Am J Clin Dermatol. 2025 Jul 29. doi: 10.1007/s40257-025-00964-6.
3

本文引用的文献

1
Prevalence and characteristics of psoriasis in Denmark: findings from the Danish skin cohort.丹麦银屑病的流行情况和特征:丹麦皮肤队列研究的结果。
BMJ Open. 2019 Mar 20;9(3):e028116. doi: 10.1136/bmjopen-2018-028116.
2
Topology of psoriasis in routine care: results from high-resolution analysis of 2009 patients.常规护理中的银屑病拓扑结构:2009 例患者的高分辨率分析结果。
Br J Dermatol. 2019 Aug;181(2):358-365. doi: 10.1111/bjd.17403. Epub 2019 Jan 24.
3
GENIPSO: a French prospective study assessing instantaneous prevalence, clinical features and impact on quality of life of genital psoriasis among patients consulting for psoriasis.
Epidemiology and clinical features of psoriasis in hard-to-treat body locations: a Chinese nationwide population-based study.难治性身体部位银屑病的流行病学及临床特征:一项基于全国人群的中国研究
BMC Immunol. 2025 Jul 3;26(1):45. doi: 10.1186/s12865-025-00724-5.
4
Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body: The ARRECTOR Phase 3 Randomized Clinical Trial.0.3% 罗氟司特泡沫剂用于头皮和身体银屑病:ARRECTOR 3期随机临床试验
JAMA Dermatol. 2025 May 7. doi: 10.1001/jamadermatol.2025.1136.
5
Efficacy and Safety of Apremilast Over 52 Weeks in Patients with Plaque Psoriasis in High-Impact Areas and Impaired Quality of Life.阿普司特治疗52周对高影响区域斑块状银屑病及生活质量受损患者的疗效和安全性
Dermatol Ther (Heidelb). 2025 May 3. doi: 10.1007/s13555-025-01389-z.
6
PSO-TARGET: a New Tool to Identify the Therapeutic Expectations of Psoriasis Patients Treated with Biologics.PSO-TARGET:一种识别接受生物制剂治疗的银屑病患者治疗期望的新工具。
Dermatol Ther (Heidelb). 2025 Mar;15(3):707-719. doi: 10.1007/s13555-025-01356-8. Epub 2025 Feb 21.
7
Real-Life Experience with Tildrakizumab in Plaque Psoriasis with Palmoplantar Involvement: A Multi-Center Retrospective Italian Study.替拉珠单抗治疗掌跖受累斑块状银屑病的真实生活经验:一项意大利多中心回顾性研究
Dermatol Ther (Heidelb). 2025 Feb;15(2):323-336. doi: 10.1007/s13555-025-01339-9. Epub 2025 Jan 23.
8
Demographics, Disease Characteristics, and Treatment Patterns of Patients with Plaque Psoriasis Treated with Biological Drugs: The Experience of a Single-Centre Study in Poland.接受生物药物治疗的斑块状银屑病患者的人口统计学、疾病特征及治疗模式:波兰一项单中心研究的经验
J Clin Med. 2024 Dec 16;13(24):7647. doi: 10.3390/jcm13247647.
9
Brodalumab Is Effective for Psoriasis Patients with Difficult-To-Treat Body Regions: Results from an Observational Clinical Study.布罗达单抗对身体部位难治性银屑病患者有效:一项观察性临床研究结果
Dermatology. 2025;241(1):80-91. doi: 10.1159/000542348. Epub 2024 Nov 6.
10
Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Psoriasis and Special Body Area Involvement: Sub-analysis of a Randomized, Double-Blind, Multicenter Phase 3 Study.司库奇尤单抗治疗中国中重度银屑病及特殊身体部位受累患者的疗效:一项随机、双盲、多中心3期研究的亚组分析
Adv Ther. 2025 Jan;42(1):146-163. doi: 10.1007/s12325-024-02976-w. Epub 2024 Sep 30.
GENIPSO:一项法国前瞻性研究,评估了就诊于银屑病患者中生殖器银屑病的即时患病率、临床特征及其对生活质量的影响。
Br J Dermatol. 2019 Mar;180(3):647-656. doi: 10.1111/bjd.17147. Epub 2018 Nov 1.
4
Real-world health outcomes in adults with moderate-to-severe psoriasis in the United States: a population study using electronic health records to examine patient-perceived treatment effectiveness, medication use, and healthcare resource utilization.美国中重度银屑病成人患者的真实世界健康结局:一项利用电子健康记录进行的人群研究,以考察患者感知的治疗效果、药物使用及医疗资源利用情况。
BMC Dermatol. 2018 Jun 28;18(1):4. doi: 10.1186/s12895-018-0072-2.
5
Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis.在一项随机、双盲、安慰剂对照的 IIIb 期研究中,评估 ixekizumab 在中重度生殖器银屑病患者中的疗效和安全性。
Br J Dermatol. 2018 Oct;179(4):844-852. doi: 10.1111/bjd.16736. Epub 2018 Jul 22.
6
How Much Pain Is Significant? Defining the Minimal Clinically Important Difference for the Visual Analog Scale for Pain After Total Joint Arthroplasty.多大的疼痛才算显著?全膝关节置换术后视觉模拟评分的最小临床重要差值定义。
J Arthroplasty. 2018 Jul;33(7S):S71-S75.e2. doi: 10.1016/j.arth.2018.02.029. Epub 2018 Feb 22.
7
Prevalence of genital psoriasis in patients with psoriasis.银屑病患者中生殖器银屑病的患病率。
J Dermatolog Treat. 2018 Dec;29(8):754-760. doi: 10.1080/09546634.2018.1453125. Epub 2018 Mar 28.
8
Guideline-compliant prescription of biologicals and possible barriers in dermatological practices in Bavaria.巴伐利亚州皮肤科实践中符合指南的生物制剂处方和可能存在的障碍。
J Eur Acad Dermatol Venereol. 2018 Jun;32(6):978-984. doi: 10.1111/jdv.14811. Epub 2018 Feb 7.
9
Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR).银屑病患者纵向评估和注册研究(PSOLAR)中的抑郁症状、抑郁症和生物治疗效果。
J Am Acad Dermatol. 2018 Jan;78(1):70-80. doi: 10.1016/j.jaad.2017.08.051. Epub 2017 Nov 6.
10
Evidence and Suggested Therapeutic Approach in Psoriasis of Difficult-to-treat Areas: Palmoplantar Psoriasis, Nail Psoriasis, Scalp Psoriasis, and Intertriginous Psoriasis.难治疗部位银屑病(掌跖银屑病、甲银屑病、头皮银屑病和间擦部位银屑病)的证据及建议治疗方法
Indian J Dermatol. 2017 Mar-Apr;62(2):113-122. doi: 10.4103/ijd.IJD_539_16.